27Sep 2023
Bivalirudin Versus Heparin During PCI in NSTEMI

Bivalirudin Versus Heparin During PCI in NSTEMI

This individual patient data meta-analysis compared bivalirudin and heparin anticoagulation in patients with non–ST–segment–elevation myocardial infarction undergoing PCI and found no significant difference in 30-day mortality, cardiac mortality, reinfarction, or stent thrombosis rates between the two methods. However, bivalirudin reduced severe bleeding, both access site–-related and non—access site–related, compared to heparin.

  • #cardiology

Like

Save

Share